← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2006Last known activity
Dec 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 6 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT07231614OfficialPhase 4Dec 20, 2025
- NCT07231614Lead sponsorPhase 4Dec 20, 2025
- NCT06704113Lead sponsorPhase 4Dec 15, 2024
- NCT05138484CollaboratorPhase 3Oct 20, 2017
- NCT05138484Lead sponsorPhase 3Oct 20, 2017
- NCT02273635Study directorPhase 1/Phase 2Sep 1, 2014
- NCT02273635CollaboratorPhase 1/Phase 2Sep 1, 2014
- NCT02280876Lead sponsorPhase 1/Phase 2Jan 1, 2012
- NCT02280876Reponsible party - principal investigatorPhase 1/Phase 2Jan 1, 2012
- NCT02280876Study directorPhase 1/Phase 2Jan 1, 2012
- NCT00749645Sponsor investigatorPhase 2Oct 1, 2006
- NCT00749645Study chairPhase 2Oct 1, 2006
- NCT00749645Lead sponsorPhase 2Oct 1, 2006
- NCT00749645Overall official - principal investigatorPhase 2Oct 1, 2006
- NCT00749645Study directorPhase 2Oct 1, 2006
Details
- Last known activity
- Dec 20, 2025